Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography–Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study
暂无分享,去创建一个
A. Evens | S. Parsons | M. Fanale | A. Surinach | C. Flores | Darcy R. Flora | Supriya Kumar | Kristina S. Yu | N. Liu | Kristina S Yu | Katie Holmes | Darcy R Flora
[1] M. Fanale,et al. Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Stage III/IV Classic Hodgkin Lymphoma Treated with Frontline ABVD: A Retrospective Analysis Using a Real-World Database , 2022, Blood.
[2] R. Advani,et al. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.
[3] R. Advani,et al. Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience. , 2021, Clinical lymphoma, myeloma & leukemia.
[4] N. Robert,et al. Real-World Adherence to National Comprehensive Cancer Network (NCCN) Guidelines Regarding the Usage of PET/CT and Reported Deauville Scores in Advanced Stage Classical Hodgkin Lymphoma: A Community Oncology Practice Perspective , 2020 .
[5] R. Advani,et al. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.
[6] G. Salles,et al. Resources-Stratified Guidelines for Classical Hodgkin Lymphoma , 2020, International journal of environmental research and public health.
[7] S. Ansell. Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management , 2018, American journal of hematology.
[8] L. Gordon,et al. Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors , 2017, Clinical Medicine Insights. Oncology.
[9] L. Quéro,et al. Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients , 2017, Oncotarget.
[10] Guidelines for good pharmacoepidemiology practice (GPP) , 2016, Pharmacoepidemiology and drug safety.
[11] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[12] O. Casasnovas,et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale , 2014, Haematologica.
[13] S. Pileri,et al. Pathobiology of Hodgkin Lymphoma , 2010, Advances in hematology.